nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Temozolomide—melanoma	0.454	0.576	CbGbCtD
Fosamprenavir—CYP3A4—Vemurafenib—melanoma	0.249	0.316	CbGbCtD
Fosamprenavir—CYP3A4—Docetaxel—melanoma	0.0853	0.108	CbGbCtD
Fosamprenavir—Opportunistic infection—Temozolomide—melanoma	0.00799	0.0377	CcSEcCtD
Fosamprenavir—Reaction gastrointestinal—Docetaxel—melanoma	0.00642	0.0303	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00349	0.0165	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Vemurafenib—melanoma	0.00311	0.0147	CcSEcCtD
Fosamprenavir—Erythema multiforme—Vemurafenib—melanoma	0.00299	0.0141	CcSEcCtD
Fosamprenavir—Cardiac disorder—Vemurafenib—melanoma	0.00294	0.0139	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Carmustine—melanoma	0.00278	0.0131	CcSEcCtD
Fosamprenavir—Malnutrition—Vemurafenib—melanoma	0.00275	0.013	CcSEcCtD
Fosamprenavir—Myalgia—Vemurafenib—melanoma	0.00235	0.0111	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00233	0.011	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00233	0.011	CcSEcCtD
Fosamprenavir—Inflammation—Docetaxel—melanoma	0.00221	0.0104	CcSEcCtD
Fosamprenavir—Nervous system disorder—Vemurafenib—melanoma	0.0022	0.0104	CcSEcCtD
Fosamprenavir—Skin disorder—Vemurafenib—melanoma	0.00218	0.0103	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Bleomycin—melanoma	0.00211	0.00994	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Temozolomide—melanoma	0.0021	0.00993	CcSEcCtD
Fosamprenavir—Myocardial infarction—Bleomycin—melanoma	0.00209	0.00988	CcSEcCtD
Fosamprenavir—Neutropenia—Dactinomycin—melanoma	0.00209	0.00986	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Temozolomide—melanoma	0.00206	0.00973	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00205	0.00967	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00197	0.00932	CcSEcCtD
Fosamprenavir—Neutropenia—Carmustine—melanoma	0.00195	0.00923	CcSEcCtD
Fosamprenavir—Decreased appetite—Vemurafenib—melanoma	0.00195	0.00922	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Vemurafenib—melanoma	0.00194	0.00916	CcSEcCtD
Fosamprenavir—Fatigue—Vemurafenib—melanoma	0.00194	0.00915	CcSEcCtD
Fosamprenavir—Haemoglobin—Bleomycin—melanoma	0.00193	0.00909	CcSEcCtD
Fosamprenavir—Haemorrhage—Bleomycin—melanoma	0.00192	0.00905	CcSEcCtD
Fosamprenavir—Neutropenia—Temozolomide—melanoma	0.00189	0.00892	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Carmustine—melanoma	0.00189	0.0089	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Temozolomide—melanoma	0.00182	0.0086	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00179	0.00843	CcSEcCtD
Fosamprenavir—Body temperature increased—Vemurafenib—melanoma	0.00178	0.00839	CcSEcCtD
Fosamprenavir—Erythema multiforme—Dactinomycin—melanoma	0.00169	0.00798	CcSEcCtD
Fosamprenavir—Haemoglobin—Carmustine—melanoma	0.00168	0.00794	CcSEcCtD
Fosamprenavir—Haemorrhage—Carmustine—melanoma	0.00167	0.0079	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vemurafenib—melanoma	0.00166	0.00782	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Carmustine—melanoma	0.00164	0.00776	CcSEcCtD
Fosamprenavir—Haemoglobin—Temozolomide—melanoma	0.00163	0.00767	CcSEcCtD
Fosamprenavir—Haemorrhage—Temozolomide—melanoma	0.00162	0.00763	CcSEcCtD
Fosamprenavir—Asthenia—Vemurafenib—melanoma	0.00161	0.00761	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Temozolomide—melanoma	0.0016	0.00754	CcSEcCtD
Fosamprenavir—Pruritus—Vemurafenib—melanoma	0.00159	0.00751	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Temozolomide—melanoma	0.00159	0.0075	CcSEcCtD
Fosamprenavir—Urethral disorder—Temozolomide—melanoma	0.00159	0.00748	CcSEcCtD
Fosamprenavir—Diarrhoea—Vemurafenib—melanoma	0.00154	0.00726	CcSEcCtD
Fosamprenavir—Erythema multiforme—Temozolomide—melanoma	0.00153	0.00722	CcSEcCtD
Fosamprenavir—Cardiac disorder—Temozolomide—melanoma	0.0015	0.00708	CcSEcCtD
Fosamprenavir—Dizziness—Vemurafenib—melanoma	0.00149	0.00702	CcSEcCtD
Fosamprenavir—Immune system disorder—Temozolomide—melanoma	0.00146	0.00689	CcSEcCtD
Fosamprenavir—Malnutrition—Carmustine—melanoma	0.00146	0.00687	CcSEcCtD
Fosamprenavir—Vomiting—Vemurafenib—melanoma	0.00143	0.00675	CcSEcCtD
Fosamprenavir—Myalgia—Bleomycin—melanoma	0.00142	0.00671	CcSEcCtD
Fosamprenavir—Rash—Vemurafenib—melanoma	0.00142	0.00669	CcSEcCtD
Fosamprenavir—Dermatitis—Vemurafenib—melanoma	0.00142	0.00668	CcSEcCtD
Fosamprenavir—Headache—Vemurafenib—melanoma	0.00141	0.00665	CcSEcCtD
Fosamprenavir—Malnutrition—Temozolomide—melanoma	0.00141	0.00664	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Docetaxel—melanoma	0.0014	0.00661	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Docetaxel—melanoma	0.00137	0.00647	CcSEcCtD
Fosamprenavir—Nausea—Vemurafenib—melanoma	0.00134	0.0063	CcSEcCtD
Fosamprenavir—Myalgia—Dactinomycin—melanoma	0.00133	0.00625	CcSEcCtD
Fosamprenavir—Anorexia—Bleomycin—melanoma	0.0013	0.00613	CcSEcCtD
Fosamprenavir—Angioedema—Temozolomide—melanoma	0.00129	0.00607	CcSEcCtD
Fosamprenavir—Neutropenia—Docetaxel—melanoma	0.00126	0.00593	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Bleomycin—melanoma	0.00124	0.00586	CcSEcCtD
Fosamprenavir—Myalgia—Carmustine—melanoma	0.00124	0.00585	CcSEcCtD
Fosamprenavir—Anorexia—Dactinomycin—melanoma	0.00121	0.00571	CcSEcCtD
Fosamprenavir—Myalgia—Temozolomide—melanoma	0.0012	0.00566	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00119	0.00562	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00119	0.00561	CcSEcCtD
Fosamprenavir—Decreased appetite—Bleomycin—melanoma	0.00118	0.00559	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Docetaxel—melanoma	0.00118	0.00557	CcSEcCtD
Fosamprenavir—Myocardial infarction—Docetaxel—melanoma	0.00117	0.00554	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00116	0.00546	CcSEcCtD
Fosamprenavir—Anorexia—Carmustine—melanoma	0.00113	0.00535	CcSEcCtD
Fosamprenavir—Nervous system disorder—Temozolomide—melanoma	0.00113	0.00532	CcSEcCtD
Fosamprenavir—Skin disorder—Temozolomide—melanoma	0.00112	0.00527	CcSEcCtD
Fosamprenavir—Decreased appetite—Dactinomycin—melanoma	0.0011	0.00521	CcSEcCtD
Fosamprenavir—Fatigue—Dactinomycin—melanoma	0.0011	0.00517	CcSEcCtD
Fosamprenavir—Anorexia—Temozolomide—melanoma	0.0011	0.00517	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Carmustine—melanoma	0.00108	0.00511	CcSEcCtD
Fosamprenavir—Haemoglobin—Docetaxel—melanoma	0.00108	0.0051	CcSEcCtD
Fosamprenavir—Body temperature increased—Bleomycin—melanoma	0.00108	0.00508	CcSEcCtD
Fosamprenavir—Haemorrhage—Docetaxel—melanoma	0.00108	0.00508	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Docetaxel—melanoma	0.00106	0.00501	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Docetaxel—melanoma	0.00106	0.00499	CcSEcCtD
Fosamprenavir—Urethral disorder—Docetaxel—melanoma	0.00105	0.00498	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Temozolomide—melanoma	0.00105	0.00494	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dactinomycin—melanoma	0.00104	0.0049	CcSEcCtD
Fosamprenavir—Decreased appetite—Carmustine—melanoma	0.00103	0.00488	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Carmustine—melanoma	0.00103	0.00484	CcSEcCtD
Fosamprenavir—Erythema multiforme—Docetaxel—melanoma	0.00102	0.0048	CcSEcCtD
Fosamprenavir—Body temperature increased—Dactinomycin—melanoma	0.001	0.00474	CcSEcCtD
Fosamprenavir—Abdominal pain—Dactinomycin—melanoma	0.001	0.00474	CcSEcCtD
Fosamprenavir—Hypersensitivity—Bleomycin—melanoma	0.001	0.00474	CcSEcCtD
Fosamprenavir—Decreased appetite—Temozolomide—melanoma	0.000999	0.00471	CcSEcCtD
Fosamprenavir—Cardiac disorder—Docetaxel—melanoma	0.000998	0.00471	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Temozolomide—melanoma	0.000992	0.00468	CcSEcCtD
Fosamprenavir—Fatigue—Temozolomide—melanoma	0.000991	0.00467	CcSEcCtD
Fosamprenavir—Asthenia—Bleomycin—melanoma	0.000977	0.00461	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Carmustine—melanoma	0.000972	0.00459	CcSEcCtD
Fosamprenavir—Immune system disorder—Docetaxel—melanoma	0.000971	0.00458	CcSEcCtD
Fosamprenavir—Pruritus—Bleomycin—melanoma	0.000964	0.00455	CcSEcCtD
Fosamprenavir—Abdominal pain—Carmustine—melanoma	0.00094	0.00444	CcSEcCtD
Fosamprenavir—Body temperature increased—Carmustine—melanoma	0.00094	0.00444	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Temozolomide—melanoma	0.000939	0.00443	CcSEcCtD
Fosamprenavir—Malnutrition—Docetaxel—melanoma	0.000936	0.00442	CcSEcCtD
Fosamprenavir—Hypersensitivity—Dactinomycin—melanoma	0.000936	0.00442	CcSEcCtD
Fosamprenavir—Asthenia—Dactinomycin—melanoma	0.000911	0.0043	CcSEcCtD
Fosamprenavir—Abdominal pain—Temozolomide—melanoma	0.000908	0.00429	CcSEcCtD
Fosamprenavir—Body temperature increased—Temozolomide—melanoma	0.000908	0.00429	CcSEcCtD
Fosamprenavir—Hypersensitivity—Carmustine—melanoma	0.000876	0.00413	CcSEcCtD
Fosamprenavir—Diarrhoea—Dactinomycin—melanoma	0.000869	0.0041	CcSEcCtD
Fosamprenavir—Vomiting—Bleomycin—melanoma	0.000866	0.00409	CcSEcCtD
Fosamprenavir—Rash—Bleomycin—melanoma	0.000859	0.00405	CcSEcCtD
Fosamprenavir—Dermatitis—Bleomycin—melanoma	0.000858	0.00405	CcSEcCtD
Fosamprenavir—Asthenia—Carmustine—melanoma	0.000853	0.00403	CcSEcCtD
Fosamprenavir—Hypersensitivity—Temozolomide—melanoma	0.000846	0.00399	CcSEcCtD
Fosamprenavir—Asthenia—Temozolomide—melanoma	0.000824	0.00389	CcSEcCtD
Fosamprenavir—Diarrhoea—Carmustine—melanoma	0.000813	0.00384	CcSEcCtD
Fosamprenavir—Pruritus—Temozolomide—melanoma	0.000813	0.00384	CcSEcCtD
Fosamprenavir—Nausea—Bleomycin—melanoma	0.000809	0.00382	CcSEcCtD
Fosamprenavir—Vomiting—Dactinomycin—melanoma	0.000808	0.00381	CcSEcCtD
Fosamprenavir—Rash—Dactinomycin—melanoma	0.000801	0.00378	CcSEcCtD
Fosamprenavir—Myalgia—Docetaxel—melanoma	0.000797	0.00376	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000792	0.00374	CcSEcCtD
Fosamprenavir—Dizziness—Carmustine—melanoma	0.000786	0.00371	CcSEcCtD
Fosamprenavir—Diarrhoea—Temozolomide—melanoma	0.000786	0.00371	CcSEcCtD
Fosamprenavir—Dizziness—Temozolomide—melanoma	0.00076	0.00359	CcSEcCtD
Fosamprenavir—Vomiting—Carmustine—melanoma	0.000756	0.00357	CcSEcCtD
Fosamprenavir—Nausea—Dactinomycin—melanoma	0.000754	0.00356	CcSEcCtD
Fosamprenavir—Rash—Carmustine—melanoma	0.00075	0.00354	CcSEcCtD
Fosamprenavir—Nervous system disorder—Docetaxel—melanoma	0.000749	0.00354	CcSEcCtD
Fosamprenavir—Dermatitis—Carmustine—melanoma	0.000749	0.00353	CcSEcCtD
Fosamprenavir—Headache—Carmustine—melanoma	0.000745	0.00351	CcSEcCtD
Fosamprenavir—Skin disorder—Docetaxel—melanoma	0.000742	0.0035	CcSEcCtD
Fosamprenavir—Vomiting—Temozolomide—melanoma	0.00073	0.00345	CcSEcCtD
Fosamprenavir—Anorexia—Docetaxel—melanoma	0.000728	0.00344	CcSEcCtD
Fosamprenavir—Rash—Temozolomide—melanoma	0.000724	0.00342	CcSEcCtD
Fosamprenavir—Dermatitis—Temozolomide—melanoma	0.000724	0.00342	CcSEcCtD
Fosamprenavir—Headache—Temozolomide—melanoma	0.00072	0.0034	CcSEcCtD
Fosamprenavir—Nausea—Carmustine—melanoma	0.000706	0.00333	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Docetaxel—melanoma	0.000696	0.00329	CcSEcCtD
Fosamprenavir—Nausea—Temozolomide—melanoma	0.000682	0.00322	CcSEcCtD
Fosamprenavir—Decreased appetite—Docetaxel—melanoma	0.000664	0.00313	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Docetaxel—melanoma	0.00066	0.00311	CcSEcCtD
Fosamprenavir—Fatigue—Docetaxel—melanoma	0.000659	0.00311	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Docetaxel—melanoma	0.000625	0.00295	CcSEcCtD
Fosamprenavir—Abdominal pain—Docetaxel—melanoma	0.000604	0.00285	CcSEcCtD
Fosamprenavir—Body temperature increased—Docetaxel—melanoma	0.000604	0.00285	CcSEcCtD
Fosamprenavir—Hypersensitivity—Docetaxel—melanoma	0.000563	0.00266	CcSEcCtD
Fosamprenavir—Asthenia—Docetaxel—melanoma	0.000548	0.00259	CcSEcCtD
Fosamprenavir—Pruritus—Docetaxel—melanoma	0.000541	0.00255	CcSEcCtD
Fosamprenavir—Diarrhoea—Docetaxel—melanoma	0.000523	0.00247	CcSEcCtD
Fosamprenavir—Dizziness—Docetaxel—melanoma	0.000505	0.00238	CcSEcCtD
Fosamprenavir—Vomiting—Docetaxel—melanoma	0.000486	0.00229	CcSEcCtD
Fosamprenavir—Rash—Docetaxel—melanoma	0.000482	0.00227	CcSEcCtD
Fosamprenavir—Dermatitis—Docetaxel—melanoma	0.000481	0.00227	CcSEcCtD
Fosamprenavir—Headache—Docetaxel—melanoma	0.000479	0.00226	CcSEcCtD
Fosamprenavir—Nausea—Docetaxel—melanoma	0.000454	0.00214	CcSEcCtD
Fosamprenavir—Amprenavir—ABCB1—melanoma	0.000311	1	CrCbGaD
